Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (71-80 of 218) with videos related to

Pageof 22
Sort By:
Thrombosis Research|May 18, 2026
Temporal trends and risk factors of extracranial major bleeding in patients with acute pulmonary embolismKonstantinos C Christodoulou, Lukas Hobohm, Katharina Mohr, et al.
International Journal of Clinical Oncology|March 28, 2013
Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patientsThomas Thomaidis, Arndt Weinmann, Martin Sprinzl, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 4, 2025
Comparative efficacy and safety of tislelizumab and other programmed cell death protein 1 inhibitors in first-line treatment of advanced gastroesophageal cancers: a systematic review and network meta-analysisJaffer A Ajani, Maria Alsina, Markus Moehler, et al.
World Journal of Gastroenterology|July 9, 2008
Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia proteinMaike Sieben, Kerstin Herzer, Maja Zeidler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancerCarl C Schimanski, Stefan Schwald, Nektaria Simiantonaki, et al.
BMC Cancer|July 11, 2019
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette studyStefan Heinrich, Marc Besselink, Markus Moehler, et al.
Canadian Journal of Gastroenterology & Hepatology|May 7, 2019
Loss of <i>LLGL1</i> Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal MetastasesAlexander Desuki, Frank Staib, Ines Gockel, et al.
Onkologie|December 3, 2010
Efficacy and safety of irinotecan-based chemotherapy for advanced colorectal cancer outside clinical trials: an observational studyMarkus Moehler, Younes Ababneh, Karl Verpoort, et al.
Scientific Reports|August 19, 2021
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patientsAnna Haupts, Anne Vogel, Sebastian Foersch, et al.
International Journal of Colorectal Disease|January 8, 2010
Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltrationTim Zimmermann, Markus Moehler, Ines Gockel, et al.
Pageof 22

Showing results (71-80 of 218) with videos related to

Sort By:
Pageof 22
Thrombosis Research|May 18, 2026
Temporal trends and risk factors of extracranial major bleeding in patients with acute pulmonary embolismKonstantinos C Christodoulou, Lukas Hobohm, Katharina Mohr, et al.
International Journal of Clinical Oncology|March 28, 2013
Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patientsThomas Thomaidis, Arndt Weinmann, Martin Sprinzl, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 4, 2025
Comparative efficacy and safety of tislelizumab and other programmed cell death protein 1 inhibitors in first-line treatment of advanced gastroesophageal cancers: a systematic review and network meta-analysisJaffer A Ajani, Maria Alsina, Markus Moehler, et al.
World Journal of Gastroenterology|July 9, 2008
Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia proteinMaike Sieben, Kerstin Herzer, Maja Zeidler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancerCarl C Schimanski, Stefan Schwald, Nektaria Simiantonaki, et al.
BMC Cancer|July 11, 2019
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette studyStefan Heinrich, Marc Besselink, Markus Moehler, et al.
Canadian Journal of Gastroenterology & Hepatology|May 7, 2019
Loss of <i>LLGL1</i> Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal MetastasesAlexander Desuki, Frank Staib, Ines Gockel, et al.
Onkologie|December 3, 2010
Efficacy and safety of irinotecan-based chemotherapy for advanced colorectal cancer outside clinical trials: an observational studyMarkus Moehler, Younes Ababneh, Karl Verpoort, et al.
Scientific Reports|August 19, 2021
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patientsAnna Haupts, Anne Vogel, Sebastian Foersch, et al.
International Journal of Colorectal Disease|January 8, 2010
Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltrationTim Zimmermann, Markus Moehler, Ines Gockel, et al.
Pageof 22